SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599901-23-000096
Filing Date
2023-11-28
Accepted
2023-11-28 06:31:35
Documents
12
Period of Report
2023-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K rna-20231127.htm   iXBRL 8-K 44562
  Complete submission text file 0001599901-23-000096.txt   178140

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20231127.xsd EX-101.SCH 1931
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rna-20231127_lab.xml EX-101.LAB 24851
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rna-20231127_pre.xml EX-101.PRE 13067
6 EXTRACTED XBRL INSTANCE DOCUMENT rna-20231127_htm.xml XML 2829
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 231441830
SIC: 2834 Pharmaceutical Preparations